Deborah Seymour
Acute Care · Torrington, CTNPI 1275175739
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 263 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 39.7% of the total. Among acute care clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 263 payments — averaging $13.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$558
- Corium, LLC$251
- Alkermes, Inc.$195
- Novo Nordisk$175
- Neurocrine Biosciences, Inc.$148
- plus $830 from 16 others
What the payments were for
- Food & beverage$3,578100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 135 | $1,421 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 48 | $558 |
| Corium, LLC | 17 | $251 |
| Alkermes, Inc. | 9 | $195 |
| Novo Nordisk | 9 | $175 |
| Neurocrine Biosciences, Inc. | 5 | $148 |
| Otsuka America Pharmaceutical, Inc. | 8 | $145 |
| Gilead | 4 | $83 |
| Lundbeck LLC | 4 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
| Johnson & Johnson | 2 | $67 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Braeburn Inc. | 3 | $54 |
| Teva Pharmaceuticals USA, Inc. | 2 | $46 |
| Indivior Inc. | 2 | $41 |
| AstraZeneca | 2 | $39 |
| Lilly USA, LLC | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Viiv Healthcare Company | 1 | $25 |
| Ardelyx, Inc. | 1 | $23 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Tris Pharma Inc | 1 | $14 |
How this compares
$3,578 in reported general payments places this provider in the 90th percentile of 239 acute care providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SpravatoEsketamine Hcl | 66 | $77,778 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $2,955 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $2,092 |
| Gabapentin | 43 | $463 |
| Pantoprazole Sodium | 15 | $424 |
| Famotidine | 13 | $259 |
| Clonazepam | 33 | $247 |
| Trazodone Hcl | 15 | $205 |
| Rosuvastatin Calcium | 11 | $198 |
| Metformin Hcl | 16 | $134 |
| Lamotrigine | 20 | $103 |
| Atorvastatin Calcium | 17 | $98 |
| Levothyroxine Sodium | 15 | $58 |
| Escitalopram Oxalate | 14 | $34 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonSpravato | $67 | $77,77866 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 239 acute care providers in Connecticut.
Other acute care in Torrington
- Hassen BorhotManchester$75K
- Terea GuimaraesBranford$36K
- Rosanna MenditeHartford$11K
- Nicola CalabreseMiddletown$9K
- Mary CicchettiHartford$7K
- Daniel MeewesHartford$7K
- Tara HalpinWethersfield$6K
- Wayne RockhillWaterbury$5K
- Katrina CarotenutiWaterbury$5K
- Caryn EckerNorwalk$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.